Answers are grounded in this paper and cite their sources.
Given the impact of insurance and race/ethnicity on CGM initiation and use, it is imperative that we target interventions to support universal access and sustained CGM use to mitigate the potential impact of provider biases and systemic disadvantage and racism. By enabling more equitable and meaningful T1D technology use, such interventions will begin to alleviate outcome disparities between youth with T1D from different backgrounds.
No takes yet. Share an insight, caveat, or question.
Tremblay et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: